According to the alterations of the viability feature and intracellular signaling to the PTEN blockade following the over-expression or ablation of endogenous PLK1, we have suggested a novel function of PLK1 in human pancreatic cancer. The gene discussed is PLK1; the disease is pancreatic neoplasm.